(FTK) Flotek Industries - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3433894090
FTK: Specialty Chemicals, Data Analytics Equipment, Logistics Services
Flotek Industries, Inc. (NYSE:FTK) is a technology-driven company specializing in green chemistry and data analytics, serving industrial and commercial markets globally. The company operates through two primary segments: Chemistry Technologies (CT) and Data Analytics (DA). The CT segment focuses on developing and distributing green specialty chemicals designed to optimize hydrocarbon production processes. These solutions cater to a diverse range of clients, including oil and gas companies, oilfield services, and renewable energy providers. The DA segment provides advanced equipment and services for analyzing hydrocarbon fluids, offering critical insights that enhance operational efficiency. Flotek employs a direct sales approach, supplemented by contractual agreements, to ensure comprehensive market coverage. Headquartered in Houston, Texas, the company has been in operation since its incorporation in 1985.
Over the next three months, Flotek Industries is expected to experience a period of consolidation based on current technical and fundamental analysis. Technically, the stock is trading below its 20-day and 50-day moving averages (SMA 20: 8.65, SMA 50: 8.66), suggesting bearish momentum. However, the 200-day SMA (6.04) indicates longer-term upward trajectory support. The Average True Range (ATR) of 0.48 signals moderate volatility, while the average 20-day volume of 180,574 reflects steady liquidity. Fundamentally, the companys forward P/E of 21.65 compared to its current P/E of 34.25 suggests investor expectations of improved earnings. The price-to-book ratio of 2.25 and price-to-sales ratio of 1.37 indicate a premium valuation. With a return on equity (RoE) of 7.50%, the company demonstrates reasonable profitability. Overall, the stock is likely to encounter resistance at the SMA 50 level and support near the SMA 200, with cautious sentiment expected due to high valuation multiples and moderate trading volume.
Additional Sources for FTK Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FTK Stock Overview
Market Cap in USD | 260m |
Sector | Energy |
Industry | Oil & Gas Equipment & Services |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 2005-07-27 |
FTK Stock Ratings
Growth 5y | 11.8% |
Fundamental | 40.1% |
Dividend | 0.0% |
Rel. Strength | 132 |
Analysts | 4.67/5 |
Fair Price Momentum | 7.74 USD |
Fair Price DCF | 0.65 USD |
FTK Dividends
No Dividends PaidFTK Growth Ratios
Growth Correlation 3m | -33.9% |
Growth Correlation 12m | 89.3% |
Growth Correlation 5y | -55.8% |
CAGR 5y | 7.32% |
CAGR/Max DD 5y | 0.09 |
Sharpe Ratio 12m | -0.70 |
Alpha | 116.14 |
Beta | 1.211 |
Volatility | 67.91% |
Current Volume | 105.5k |
Average Volume 20d | 216.2k |
As of April 04, 2025, the stock is trading at USD 8.37 with a total of 105,476 shares traded.
Over the past week, the price has changed by -1.88%, over one month by +13.57%, over three months by -9.02% and over the past year by +122.61%.
Partly, yes. Based on ValueRay Fundamental Analyses, Flotek Industries (NYSE:FTK) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.10 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FTK as of April 2025 is 7.74. This means that FTK is currently overvalued and has a potential downside of -7.53%.
Flotek Industries has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy FTK.
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, FTK Flotek Industries will be worth about 8.9 in April 2026. The stock is currently trading at 8.37. This means that the stock has a potential upside of +5.73%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 10.3 | 23.4% |
Analysts Target Price | 8.7 | 3.6% |
ValueRay Target Price | 8.9 | 5.7% |